EPTIS
BAM Logo

Clinical PT - TLR Coronavírus (SARS-CoV2): antigen

[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]

EPTIS factsheet 705752 | Last revision 2020-09-10 | URL: https://www.eptis.bam.de/pts705752 https://www.eptis.bam.de/pts705752

PT provider
PT provider ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda
Based in Brazil
Language(s) Portuguese/ English / Spanish
Remarks
Keywords
Product groups Health care / medical devices
Human test material
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised cell suspension Coronavírus (SARS-CoV2) Routine laboratory method
Qualitative analysis
Aims of the PT scheme
Target group of participants No restrictions.
Linked to specific legislation / standards ABNT NBR ISO/IEC 17043
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by Coordenação Geral de Acreditação do Inmetro - Cgcre on the basis of ABNT NBR ISO/IEC 17043:2011, anexo B2, B.2.4

Operation is commissioned / requested by
Fees and frequency
Participation fee
Regularly operated Yes (4 rounds per year)
Year of first operation 2020
Contact details of the PT provider
Provider Contact person
ControlLab Controle de Qualidade para Laboratórios Ltda
Rua Ana Neri 416 Benfica
20911-442 Rio de Janeiro
Brazil

Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Web: http://www.controllab.com.br http://www.controllab.com.br
Vinicius Biasoli
Phone: +55-21-3891 9900
Fax: +55-21-3891 9901
Email: eptis@controllab.com eptis@controllab.com
If you find any mistakes please contact the responsible EPTIS coordinator in Brazil, Mr José Ricardo Bardellini da Silva. Mr José Ricardo Bardellini da Silva.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21